Xueliang Gao, Yongxia Wu, Joel M Chick, Andrea Abbott, Baishan Jiang, David J Wang, Susana Comte-Walters, Roger H Johnson, Nathaniel Oberholtzer, Michael I Nishimura, Steven P Gygi, Anand Mehta, Denis C Guttridge, Lauren Ball, Shikhar Mehrotra, Piotr Sicinski, Xue-Zhong Yu, Haizhen Wang
Elucidating the mechanisms of resistance to immunotherapy and developing strategies to improve its efficacy are challenging goals. Bioinformatics analysis demonstrates that high CDK6 expression in melanoma is associated with poor progression-free survival of patients receiving single-agent immunotherapy. Depletion of CDK6 or cyclin D3 (but not of CDK4, cyclin D1, or D2) in cells of the tumor microenvironment inhibits tumor growth. CDK6 depletion reshapes the tumor immune microenvironment, and the host anti-tumor effect depends on cyclin D3/CDK6-expressing CD8+ and CD4+ T cells...
March 30, 2023: Cell Reports